<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_SFLS_Shenzhen_Experiments skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:SFLS Shenzhen/Experiments</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><UL id="navigation"><A href="https://2018.igem.org/Team:SFLS_Shenzhen">SFLS iGEM</A><LI class="sub"><A href="#">Porject</A></LI><LI><A href="https://2018.igem.org/Team:SFLS_Shenzhen/Description">Description</A></LI><LI><A href="https://2018.igem.org/Team:SFLS_Shenzhen/Design">Design</A></LI><LI><A href="https://2018.igem.org/Team:SFLS_Shenzhen/Experiments">Experiments</A></LI></UL><LI class="sub"><A href="#">Parts</A></LI><LI><A href="https://2018.igem.org/Team:SFLS_Shenzhen/Basic_Parts">Basic Parts</A></LI><LI><A href="https://2018.igem.org/Team:SFLS_Shenzhen/Composite_Parts">Composite Parts</A></LI><LI class="sub"><A href="#">Human Practices</A></LI><LI><A href="https://2018.igem.org/Team:SFLS_Shenzhen/HP_Silver">HP Silver</A></LI><LI><A href="https://2018.igem.org/Team:SFLS_Shenzhen/HP_Gold">HP Gold</A></LI><LI><A href="https://2018.igem.org/Team:SFLS_Shenzhen/Integrated_HP">Integrated HP</A></LI><LI><A href="https://2018.igem.org/Team:SFLS_Shenzhen/Public_Engagement">Public Engagement</A></LI><LI class="sub"><A href="#">Modeling</A></LI><LI><A href="https://2018.igem.org/Team:SFLS_Shenzhen/Modeling">Prediction Model</A></LI><LI class="sub"><A href="#">Team</A></LI><LI><A href="https://2018.igem.org/Team:SFLS_Shenzhen/About_Our_Team">About Our Team</A></LI><LI><A href="https://2018.igem.org/Team:SFLS_Shenzhen/Collaborations">Collaborations</A></LI><LI><A href="https://2018.igem.org/Team:SFLS_Shenzhen/Notebook">Notebook</A></LI><LI><A href="https://2018.igem.org/Team:SFLS_Shenzhen/Attributions">Attributions</A></LI><LI class="sub"><A href="#">Judging</A></LI><LI><A href="https://2018.igem.org/Team:SFLS_Shenzhen/Achievement">Achievement</A></LI><LI><A href="https://2018.igem.org/Team:SFLS_Shenzhen/Interlab">Interlab</A></LI><LI><A href="https://2018.igem.org/Team:SFLS_Shenzhen/Improvement">Improvement</A></LI></P><DIV id="experiments-title"><CENTER><H1>Experiments</H1></CENTER></DIV><DIV><CENTER><SPECIALH2>1,purpose</SPECIALH2></CENTER><DIV id="ex1-content"><P>
Studies have shown that miR-155 and miR-10b have high value in the serum of breast cancer patients. The traditional microRNA detection method is the RT-PCR method, which requires high quality reagents and equipment. In order to pre-screen breast cancer, this experiment intends to simultaneously detect the expression of miR-155 and miR-10b through a tandem toehold switch structure.
</P></DIV><DIV><CENTER><SPECIALH2>2,structure</SPECIALH2></CENTER><DIV id="ex2-image"><DIV><CENTER><SPECIALH2>3.1 design and combined genes</SPECIALH2></CENTER><DIV id="“ex1-img&quot;"><P>miR-155： double strands DNA</P></DIV><DIV id="“ex2-img&quot;"><P>miR-10b： double strands DNA </P></DIV><DIV id="“ex3-img&quot;"><P>Toehold Switch A： Insert between the EcoliI and Pstl cleavage sites in the pSB1C3 backbone plasmid
 </P></DIV><DIV id="“ex4-img&quot;"><P>Toehold Switch B： Insert between the EcoliI and Pstl cleavage sites in the pSB1C3 backbone plasmid
</P></DIV><DIV id="“ex5-img&quot;"><P>Trigger C： Insert between the EcoliI and Pstl cleavage sites in the pSB1C3 backbone plasmid</P></DIV><DIV id="“ex6-img&quot;"><P>Toehold switch c</P></DIV><DIV><CENTER><H2>4.composing miR-155 and miR-10b outside human body</H2></CENTER><P>
used kit：NEB HiScribe™ T7 Quick High Yield RNA Synthesis Kit

reaction system：

Nuclease-Free water        17μL

NTP Buffer Mix             10μL

Template DNA             1μL(1μg)

T7 RNA polymerase Mix     2	μL

Total reaction volume       30μL

37 celcius Overnight incubation

10 reactions in each experiment (Note: template purification, experimental methods, RNA purification and determination are in accordance with the instructions)
</P></DIV><DIV><DIV id="ex8-content"><P>
Dried after mixing and resuspended in 10 μL of RNase-Free Water.
</P></DIV><DIV><CENTER><H2>Plasmid amplification, screening and extraction</H2></CENTER><DIV id="ex9-content"><P>
Four plasmids of Toehold Switch A, Toehold Switch B, Trigger C and Toehold Switch C were transferred into DH5α competent state, screened with chloramphenicol agar plates, selected for monoclonal, and expanded with LB(100 mL) medium containing chloramphenicol. The plasmid was extracted with a TIANGEN plasmid extraction kit, and the plasmid concentration was measured by NanoDrop. After drying, it was resuspended in 10 μL of LTE solution for use.
</P></DIV><DIV><DIV id="ex11-content"><P>
pre-experiment

used kit： Thermofisher Expressway™ Maxi Cell-Free E. coli Expression System

system：

Tigger RNA                         1μg 0.5μg/RNA

E. coli slyD- Extract                  20 µl

2.5X IVPS E. coli Reaction Buffer (-A.A.) 20 µl

50 mM Amino Acids (-Met)           1.25 µl

75 mM Methionine*                  1 µl

T7 Enzyme Mix                      1 µl

DNA Template                      1 µg 0.5μg/plasmid

DNase/RNase-free Distilled Water To a final volume of 50 µl

add following reagent

2X IVPS Feed Buffer                 25 µl

50 mM Amino Acids (-Met)          1.25 µl

75 mM Methionine*                 1 µl

DNase/RNase-free Distilled Water To final volume of 50 µl

37℃shaker 200rpm incubate1.5h

Fluorescence expression was detected under ultraviolet light, and the Trigger-free group was used as a control.
</P></DIV><DIV><DIV id="ex13-content"><CENTER><H2>Gradient experiment</H2></CENTER><P>According to the amount of Trigger RNA, 16 groups were set up, with 5 replicates in each group. The experimental system was based on the pre-experimental system. The experimental container was a black-bottom 96-well plate, and the detection instrument was Molecular Devices FilterMax F3。
We make different concentrations of two kinds of miRNAs to get comprehensive data to simulate various detecting situations. By using NEB’s HiScribe™ T7 Quick High Yield RNA Synthesis Kit to get enough miRNA for the experiment. For the in vitro transcription, we used the Thermofisher Expressway™ Maxi Cell-Free E. coli Expression System. </P></DIV><DIV><DIV id="ex15-content"><P>As you can see, we divided the miRNA into 4 different concentration and add plasmids with toehold switches in them. To read the plates, we used Molecular Devices FilterMax F3 to get their florescence intensity, below are the results.
</P></DIV><DIV><DIV id="ex17-content"><P>From the graph we can learn that if there’s just one miRNA present, there will be no florescence, and the intensity grows with the concentration of two miRNAs, which proves our circuit is doable. 
</P></DIV><DIV><CENTER><H2>Conclusion and deficiency</H2></CENTER><DIV id="ex18-content"><P>
conclusion

1,As shown in the above results, the Toehold Switch structure we designed can perform tandem detection for miR-155 and miR-10b, ie, when the miR-155 and miR-10b are present, the Toehold Switch structure can be started.

2,The detected fluorescence intensity is related to the content of both miR-155 and miR-10b. As the content of the two increases, the fluorescence intensity is correspondingly enhanced;

deficiency

1,The linear study of the whole test in this experiment can be further developed;

This experiment did not study the detection of breast cancer positive samples, and the indication effect of miR-155 and miR-10b on breast cancer remains to be studied.
</P></DIV><DIV><CENTER><H2> Future </H2></CENTER><P> We proved our project can be done in the lab, but we don’t know whether it’ll work in realistic conditions. The further task is to find the relationship in florescence intensity between normal human serum and patients’ and to make this project go in to the public world. </P></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>